Guillén, Núria http://orcid.org/0000-0002-1341-9834
Contador, José
Buongiorno, Mariateresa
Álvarez, Ignacio
Culell, Natalia
Alcolea, Daniel
Lleó, Alberto
Fortea, Juan
Piñol-Ripoll, Gerard
Carnes-Vendrell, Anna
Lourdes Ispierto, María
Vilas, Dolores
Puig-Pijoan, Albert
Fernández-Lebrero, Aida
Balasa, Mircea
Sánchez-Valle, Raquel
Lladó, Albert
Funding for this research was provided by:
Instituto de Salud Carlos III (PI19/00449, FI20/00076, PI18/00435, INT19/00016, PI17/01896, AC19/00103, PI14/01126, PI17/01019, PI20/01473)
Departament de Salut, Generalitat de Catalunya (PERIS 2016-2020 SLT008/18/00061, PERIS 2019 SLT008/18/00050, SLT006/17/125, PERIS SLT002/16/408, AGAUR, SLT006/17/119)
Diputació de Lleida (PIRS2021)
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (Program 1, Alzheimer Disease)
Fundació la Marató de TV3 (20142610, 20141210)
Fundación BBVA
Foundation for the National Institutes of Health (1R01AG056850-01A1, R21AG056974, R01AG061566)
Fundació Docència i Recerca Mútua de Terrassa (2022)
Universitat de Barcelona
Article History
Received: 13 February 2023
Accepted: 2 October 2023
First Online: 28 October 2023
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest. This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI19/00449 (to A Lladó) and co-funded by the European Union and CERCA Program/Generalitat de Catalunya. Albert Lladó also received funding from Departament de Salut – Generalitat de Catalunya (PERIS 2016–2020 SLT008/18/00061). Núria Guillén received funding by Instituto de Salud CarlosIII (ISCIII) through the project FI20/00076 and co-funded by the European Union. Gerard Piñol-Ripoll received fundind from the Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050) and the IRBLleida-Diputació de Lleida (PIRS2021). Daniel Alcolea received funding from Institute of Health Carlos III (ISCIII), Spain PI18/00435 and INT19/00016, and the Department of Health Generalitat de Catalunya PERIS program SLT006/17/125. Alberto Lleó received research grants from CIBERNED (Program 1, Alzheimer Disease), Institute of Health Carlos III (PI17/01896 and AC19/00103), Generalitat de Catalunya (PERIS SLT002/16/408 and AGAUR), Fundació La Marató de TV3 (20142610) and Fundación BBVA. Juan Fortea received research grants from Institute of Health Carlos III (PI14/01126, PI17/01019 and PI20/01473), National Institutes of Health (1R01AG056850-01A1; R21AG056974; and R01AG061566), Fundació La Marató de TV3 (20141210), and Pla Estratègic de Recerca i Innovació en Salut (PERIS) SLT006/17/119. Mariateresa Buongiorno was supported by a grant awarded by Fundació Docència i Recerca MútuaTerrassa (2022).
: Approval was obtained from the six centers Ethics Committees. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.